StockNews.com began coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Free Report) in a research report sent to investors on Tuesday. The firm issued a hold rating on the biopharmaceutical company’s stock.
Sorrento Therapeutics Stock Performance
Sorrento Therapeutics stock opened at $0.00 on Tuesday. The stock’s 50 day moving average price is $0.01 and its 200 day moving average price is $0.01. Sorrento Therapeutics has a 1-year low of $0.00 and a 1-year high of $0.25.
Sorrento Therapeutics Company Profile
Further Reading
- Five stocks we like better than Sorrento Therapeutics
- How to Most Effectively Use the MarketBeat Earnings Screener
- Why Meta’s Pre-Earnings Dip Could Be A Golden Entry Opportunity
- Want to Profit on the Downtrend? Downtrends, Explained.
- Spirit Airlines Stock Nearly Doubled: Are Clear Skies Ahead?
- Golden Cross Stocks: Pattern, Examples and Charts
- Tesla Stock: Buy the Dips, Sell the Rips
Receive News & Ratings for Sorrento Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sorrento Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.